These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6310997)

  • 1. Efficacy of amdinocillin and lack of nephrotoxicity when combined with a second beta-lactam antibiotic for therapy of serious gram-negative bacillary infections.
    Sattler FR; Hall S; Hanna CE; Green EA
    Am J Med; 1983 Aug; 75(2A):106-12. PubMed ID: 6310997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic infections treated with amdinocillin in combination with other beta-lactam antibiotics.
    King JW; Beam TR; Neu HC; Smith LG
    Am J Med; 1983 Aug; 75(2A):90-5. PubMed ID: 6311013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amdinocillin in combination with beta-lactam antibiotics for treatment of serious gram-negative infections.
    Rotstein C; Farrar WE
    Am J Med; 1983 Aug; 75(2A):96-9. PubMed ID: 6311014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination amdinocillin and cefoxitin therapy of multiply-resistant Serratia marcescens urinary tract infections.
    Ward TT; Amon MB; Krause LK
    Am J Med; 1983 Aug; 75(2A):85-9. PubMed ID: 6311011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenteral amdinocillin for treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1983 Aug; 75(2A):82-4. PubMed ID: 6311010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of clinical experience with amdinocillin monotherapy and comparative studies.
    Demos CH; Green E
    Am J Med; 1983 Aug; 75(2A):72-81. PubMed ID: 6311009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections).
    File TM; Tan JS
    Am J Med; 1983 Aug; 75(2A):100-5. PubMed ID: 6310996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections.
    Nelson JD; Kusmiesz H; Shelton S
    Am J Med; 1983 Aug; 75(2A):125-9. PubMed ID: 6311000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin.
    Lawson RD; Estey EH; Bodey GP
    Am J Med; 1983 Aug; 75(2A):113-8. PubMed ID: 6310998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amdinocillin therapy of experimental animal infections.
    Gordin FM; Sande MA
    Am J Med; 1983 Aug; 75(2A):48-53. PubMed ID: 6311005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mecillinam and ampicillin separately or combined in gram-negative septicemia.
    Ekwall E; Scheja A; Cronberg S; Ganrot-Norlin K; Jonsson M; Juhlin I; Kahlmeter G; Thorén A; Thulin KE; Tunevall G
    Infection; 1980; 8(1):37-40. PubMed ID: 6246006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.
    Cleeland R; Squires E
    Am J Med; 1983 Aug; 75(2A):21-9. PubMed ID: 6311002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria.
    Eng RH; Liu R; Smith SM; Johnson ES; Cherubin CE
    Chemotherapy; 1988; 34(1):18-26. PubMed ID: 3258230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
    Ereshefsky BJ; Al-Hasan MN; Gokun Y; Martin CA
    J Chemother; 2017 Feb; 29(1):30-37. PubMed ID: 27376664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mecillinam in urinary tract infections and in septicaemia.
    Frimodt-Møller N; Ravn TJ
    Infection; 1979; 7(1):35-7. PubMed ID: 217836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.